Startseite Low hormone levels during an attack of systemic capillary leak syndrome normalizing after treatment
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Low hormone levels during an attack of systemic capillary leak syndrome normalizing after treatment

  • Jean-Baptiste Davion ORCID logo , Sébastien Sanges EMAIL logo , Amjad Ghulam , Marc Lambert , Sandrine Morell-Dubois , Cécile Yelnik , Vincent Sobanski , Eric Hachulla , David Launay und Claire Douillard
Veröffentlicht/Copyright: 20. Mai 2020
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

We report herein the case of a patient with low blood levels of different hormones during a systemic capillary leak syndrome (Clarkson’s disease) attack.

Author statement

  1. Research funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

  2. Conflict of interest: The authors (Jean-Baptiste Davion, Sébastien Sanges, Amjad Ghulam, Marc Lambert, Sandrine Morell-Dubois, Cécile Yelnik, Vincent Sobanski, Eric Hachulla, David Launay, Claire Douillard) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

  3. Informed consent: Informed consent has been obtained from the patient for publication of the case report and accompanying images.

  4. Ethical approval: Not applicable.

References

[1] Clarkson B, Thompson D, Horwith M, Luckey EH. Cyclical edema and shock due to increased capillarity permeability. Am J Med. 1960;29:193–216.10.1016/0002-9343(60)90018-8Suche in Google Scholar PubMed

[2] Baloch NU, Bikak M, Rehman A, Rahman O. Recognition and management of idiopathic systemic capillary leak syndrome: an evidence-based review. Expert Rev Cardiovasc Ther. 2018;16:331–40.10.1080/14779072.2018.1456920Suche in Google Scholar PubMed

[3] Atkinson JP, Waldmann TA, Stein SF, Gelfand JA, Macdonald WJ, Heck LW, et al. Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore). 1977;56:225–39.10.1097/00005792-197705000-00004Suche in Google Scholar PubMed

[4] Scanvion Q, Lefèvre G, Hachulla E, Hatron PY, Lambert M. Subcutaneous immunoglobulin therapy prevents systemic capillary leak syndrome attack. Am J Med. 2016;129:e77–8.10.1016/j.amjmed.2016.02.046Suche in Google Scholar PubMed

[5] Then C, Ritzel K, Seibold C, Mann JF, Reincke M. Multiglandular hormone deficiency in a patient with systemic capillary leak syndrome. Case Rep Med. 2015;2015:958283.10.1155/2015/958283Suche in Google Scholar PubMed PubMed Central

Received: 2020-01-18
Accepted: 2020-03-09
Published Online: 2020-05-20

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Special Section: "Update in the management of ovarian cancer"; Guest Editors: René Druckmann and Adolf E. Schindler
  2. Editorial
  3. Preface to special issue: update in the management of ovarian cancer
  4. Original Article
  5. Ovarian cancer screening in the general population
  6. Review Articles
  7. Non-surgical prevention strategies in women with hereditary breast and ovarian cancer syndromes
  8. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update
  9. Genetic testing in ovarian cancer – clinical impact and current practices
  10. The place of secondary complete cytoreductive surgery in advanced ovarian cancer
  11. An update on preoperative assessment of the resectability of advanced ovarian cancer
  12. Impact of retroperitoneal lymph node dissection in ovarian cancer – time for paradigm shift?
  13. Minireviews
  14. Ultrasound screening of ovarian cancer
  15. How to manage BRCA mutation carriers?
  16. Regular Issue
  17. Original Articles
  18. Progestogen addition with low-dose levonorgestrel intrauterine system in menopausal hormone treatment gives less normal breast tissue proliferation than oral norethisterone acetate or medroxyprogesterone acetate
  19. The effectiveness of military physical exercise on irisin concentrations and oxidative stress among male healthy volunteers
  20. Periodontal status and bone metabolism in women in reproductive and postmenopausal periods
  21. Modulatory effect of tropisetron in the liver of streptozotocin-induced diabetes in rats: biochemical and histological evidence
  22. Celecoxib versus mefenamic acid in the treatment of primary dysmenorrhea
  23. The predictive role of amylase and lipase levels on pancreas injury diagnosis in patients with blunt abdominal trauma
  24. Case Report
  25. Low hormone levels during an attack of systemic capillary leak syndrome normalizing after treatment
Heruntergeladen am 15.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2020-0004/html
Button zum nach oben scrollen